Litigation Details for Radius Health, Inc. v. Orbicular Pharmaceutical Technologies Private Limited (D. Mass. 2024)

Radius Health, Inc. v. Orbicular Pharmaceutical Technologies Private Limited (D. Mass. 2024)

Docket		Date Filed	2024-07-10
Court	District Court, D. Massachusetts	Date Terminated
Cause	35:271 Patent Infringement	Assigned To	Richard Gaylore Stearns
Jury Demand	None	Referred To
Parties	RADIUS HEALTH, INC.
Patents	11,977,067
Attorneys	Rebecca Lynne Neubauer
Firms	Choate, Hall & Stewart
Link to Docket	External link to docket

Details for Radius Health, Inc. v. Orbicular Pharmaceutical Technologies Private Limited (D. Mass. 2024)

Date Filed	Document No.	Description	Snippet	Link To Document
2024-07-10				External link to document

Litigation summary and analysis for: Radius Health, Inc. v. Orbicular Pharmaceutical Technologies Private Limited (D. Mass. 2024)

Last updated: April 26, 2026

Radius Health v. Orbicular Pharma (D. Mass.) — 1:24-cv-11770: What the record shows

Radius Health, Inc. sued Orbicular Pharmaceutical Technologies Private Limited in the U.S. District Court for the District of Massachusetts (case no. 1:24-cv-11770) in 2024. The case centers on pharmaceutical IP and the statutory mechanisms typically implicated by an ANDA-related posture, but the available information in this workspace does not include the complaint, claims, asserted patents, litigation stage, or any court orders needed to produce an accurate litigation summary tied to specific patent numbers, product identifiers, and procedural milestones.

Can a complete litigation summary be produced from the provided record?

No. A proper Bloomberg-style litigation summary requires, at minimum, verifiable inputs that are not present here: the complaint (and its factual allegations), the asserted patent list (publication and/or patent numbers), the product or label references at issue, the procedural history (Rule 12/answer, scheduling order, Markman posture, claim construction dates, injunction briefing, discovery, or motions decided), and the docket outcomes. Without those, any statement about what was asserted, what was decided, or what the parties argued would risk being incomplete or inaccurate.

What would the analysis cover if the core filings were available?

A complete analysis would map the case to litigation risk and business impact using a standard template:

• Parties and asserted rights

  • Radius Health as plaintiff; Orbicular Pharmaceutical Technologies Private Limited as defendant
  • Asserted patent set (patent numbers, expiration, priority dates, family structure)
  • Asserted infringement theory (direct, induced, contributory; method vs composition claims)

• Procedural posture

  • Complaint filing date and jurisdictional basis
  • Any motions to dismiss, transfer, stay, or venue challenges
  • Answer and defenses (non-infringement, invalidity, unenforceability, jurisdictional or procedural defenses)
  • Whether any preliminary injunction or emergency relief was sought and the ruling, if any
  • Claim construction scheduling and whether the court has issued orders

• Technical claim-construction and product mapping

  • Claim elements tied to formulation, method steps, device/administration, or manufacturing parameters
  • Defendant’s proposed product attributes and where infringement is alleged

• Validity attack profile

  • Anticipation/obviousness grounds tied to specific prior art references
  • Inequitable conduct or prosecution history estoppel theories (if pled)
  • Laches and patent misuse defenses (if pled)

• Business implications

  • Expected infringement/validity leverage by patent type and claim scope
  • Litigation timeline markers (stay likelihood, discovery gates, trial date)
  • Settlement pressure points

Key Takeaways

• The case caption and docket number are identified: Radius Health, Inc. v. Orbicular Pharmaceutical Technologies Private Limited, 1:24-cv-11770 (D. Mass.).
• A litigation summary and analysis that is accurate at the level of asserted patents, claims, motions, and rulings cannot be completed from the information available in this workspace.

FAQs

1. What is the case number for Radius Health’s suit against Orbicular Pharmaceutical Technologies?
   1:24-cv-11770.

2. Which court is handling the matter?
   The U.S. District Court for the District of Massachusetts.

3. Who are the plaintiff and defendant?
   Radius Health, Inc. (plaintiff); Orbicular Pharmaceutical Technologies Private Limited (defendant).

4. What stage is the case in?
   The procedural stage and any rulings are not provided in the available record here.

5. Which patents are at issue?
   The asserted patent numbers and claims are not provided in the available record here.

---

References (APA)

[1] U.S. District Court for the District of Massachusetts. Radius Health, Inc. v. Orbicular Pharmaceutical Technologies Private Limited, No. 1:24-cv-11770 (2024).